Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.23
Delayed Data
As of May 21
 +0.63 / +39.37%
Today’s Change
0.61
Today|||52-Week Range
3.50
+165.41%
Year-to-Date

Today’s Trading

Previous close1.60
Today’s open1.84
Day’s range-- - --
Volume94,274,412
Average volume (3 months)2,976,078
Market cap$88.1M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+51.90%
Earnings growth (this year)+20.79%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,301.62%
P/E ratioNM
Price/Sales2.42
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
EVARLombard Medical Inc+0.11+2.01%
VICLVical Inc-0.04-4.30%
GLMDGalmed Pharmaceutica...+0.18+2.18%
NNVCNanoViricides Inc-0.02-1.23%
Data as of 05/21/2015

Financials

Last reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$18.1M
Annual profit (last year)-$52.7M
Net profit margin-291.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers